Ka
Non vérifié

Kashiv Biosciences, LLC

Ce que nous écrivons

BiotechnologieIndustrieIndustrie pharmaceutiqueSantéScience
22/04/2026
Multimédia
Marché financier
Santé
Science
Santé Publique
Industrie pharmaceutique
Biotechnologie
Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader
1.00
09/02/2026
Marché du travail
Industrie
Science
Biotechnologie
Industrie pharmaceutique
Santé Publique
Santé
Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Product in Europe, the UK & India
1.00
06/01/2026
Biotechnologie
Industrie pharmaceutique
Santé
Événements
Expos
Kashiv BioSciences sarà presente alla 44ª conferenza annuale sulla sanità di J.P. Morgan
1.00
06/01/2026
Biotechnologie
Industrie pharmaceutique
Santé
Événements
Expos
Kashiv BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
1.00
24/09/2025
Marché du travail
Industrie
Oncologie
Santé
Science
Industrie pharmaceutique
Biotechnologie
Kashiv BioSciences and JAMP Pharma Corporation Announce the Launch of PEXEGRA® and FILRA® Biosimilars in Canada
1.00
11/09/2025
Science
Biotechnologie
Industrie pharmaceutique
Santé Publique
Santé
Marché du travail
Industrie
Kashiv BioSciences and CRISTÁLIA Enter into Licensing and Supply Agreement for Omalizumab Biosimilar (ADL-018) in Latin America
1.00
05/08/2025
Santé
Médecine - Divers
Science
Industrie pharmaceutique
Biotechnologie
Marché du travail
Industrie
Kashiv BioSciences and MS Pharma Enter into MENA License and Supply Agreement for ADL-018, Biosimilar Candidate to XOLAIR® (bOmalizumab)
1.00
25/06/2025
Science
Hygiène alimentaire
Médecine - Divers
Biotechnologie
Santé
Industrie pharmaceutique
Santé Publique
Industrie
Kashiv BioSciences Announces Positive Topline Results from Confirmatory Efficacy Study of ADL-018, Biosimilar Candidate to XOLAIR® (omalizumab)
1.00
07/04/2025
Marché du travail
Santé
Science
Industrie pharmaceutique
Biotechnologie
Kashiv BioSciences Secures $150 Million Debt Financing from GoldenTree Asset Management
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0